Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Evoke Pharma Q4 Sales $3.31M Beat $3.08M Estimate

Author: Benzinga Newsdesk | March 13, 2025 04:14pm
Evoke Pharma (NASDAQ:EVOK) reported quarterly sales of $3.31 million which beat the analyst consensus estimate of $3.08 million by 7.26 percent. This is a 97.37 percent increase over sales of $1.68 million the same period last year.

Posted In: EVOK


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist